AWMGS sequencing consumables come from Oxford Nanopore Technologies
- Cardiff and Vale University Health Board
- Below threshold - without competition
- 21 October 2026 to 31 March 2027
Cardiff and Vale University Health Board bought sequencing consumables from Oxford Nanopore Technologies for the All Wales Medical Genomics Service (AWMGS). The consumables are proprietary to Oxford Nanopore. They support research at AWMGS and its investigations into clinical utility.
The health board awarded the £33,080 contract directly in October 2026, and it runs to March 2027.
Contract ends March 2027
- What
- Genomic sequencing platforms and consumables
- Supplier
- Oxford Nanopore Technologies
- Value
- £33,080
- How it was bought
- Below threshold - without competition
- Dates and next
- Oct 2026 to Mar 2027